JPRN-UMIN000009905尚未招募未知
Effects of teneligliptin for atherosclerosis-related biomarkers in patients with type 2 diabetes mellitus - atherosclerosis and teneligliptin
First Department of internal Medicine, Kansai Medical University0 个研究点目标入组 60 人开始时间: 2013年2月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The effects of Teneligliptin on vascular inflammatory markers in post-PCI (Percutaneous Coronary Intervention) patients.Coronary Artery DiseaseJPRN-UMIN000027224Kameda Medhical Center20
已完成
不适用
Effect of teneligliptin on endothelial dysfunction induced by postprandial hypelipidemiaMetabolic syndromeJPRN-UMIN000012588Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences20
已完成
不适用
The effects of Teneligliptin on endothelial function in type 2 diabetes mellitus with chronic kidney diseaseType 2 diabetes mellitus with chronic kidney diseaseJPRN-UMIN000017180Dokkyo Medical University50
招募中
不适用
The effects of teneligliptin on cardiac function and endothelial function in patients with type 2 diabetesJPRN-UMIN000012120Dokkyo Medical University40
已完成
4 期
Clinical Study for the Effect of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-UMIN000014589TOPLEVEL study office936